Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2012

Open Access 01-12-2012 | Research article

Increased risk of cancer in patients with type 2 diabetes mellitus: A retrospective cohort study in China

Authors: Pian-Hong Zhang, Zhong-Wen Chen, Duo Lv, Yu-Yang Xu, Wei-Ling Gu, Xu-Hui Zhang, Yuan-Luo Le, Hong-hong Zhu, Yi-Min Zhu

Published in: BMC Public Health | Issue 1/2012

Login to get access

Abstract

Background

Previous studies indicated that type 2 diabetes mellitus (T2DM) might be associated with the risk of cancer. The aim of this study was to investigate the association between T2DM and the risk of developing common cancers in a Chinese population.

Methods

A population-based retrospective cohort study was carried out in the Nan-Hu district of Jiaxing city, Zhejiang province, China. The incidence of cancer cases among type 2 diabetic patients were identified through record-linkage of the Diabetic Surveillance and Registry Database with the Cancer Database from January 2002 to June 2008. The standardized incidence ratio (SIR) and 95% confidence interval (CI) were estimated for the risk of cancer among the patients with type 2 diabetes.

Results

The overall incidence of cancer was 1083.6 per 105 subjects in male T2DM patients and 870.2 per 105 in females. Increased risk of developing cancer was found in both male and female T2DM patients with an SIR of 1.331 (95% CI = 1.143-1.518) and 1.737 (1.478-1.997), respectively. As for cancer subtypes, both male and female T2DM patients had a significantly increased risk of pancreatic cancer with the SIRs of 2.973 (1.73-4.21) and 2.687 (1.445-3.928), respectively. Elevated risk of liver and kidney cancers was only found in male T2DM patients with SIRs of 1.538 (1.005-2.072) and 4.091 (1.418-6.764), respectively. Increased risks of developing breast cancer [2.209 (1.487-2.93)] and leukemia SIR: [4.167 (1.584- 6.749) ] were found in female patients.

Conclusions

These findings indicated that patients with T2DM have an increased risk of developing cancer. Additional cancer screening should be employed in the management of patients with T2DM.
Literature
1.
Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004, 27: 1047-1053. 10.2337/diacare.27.5.1047.CrossRefPubMed
2.
Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, et al: Prevalence of Diabetes among Men and Women in China. New England Journal of Medicine. 2010, 362: 1090-1101. 10.1056/NEJMoa0908292.CrossRefPubMed
3.
Hyvarinen M, Tuomilehto J, Laatikainen T, Soderberg S, Eliasson M, Nilsson P, Qiao Q: The impact of diabetes on coronary heart disease differs from that on ischaemic stroke with regard to the gender. Cardiovasc Diabetol. 2009, 8: 17-10.1186/1475-2840-8-17.CrossRefPubMedPubMedCentral
4.
Huxley R, Barzi F, Woodward M: Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ. 2006, 332: 73-78. 10.1136/bmj.38678.389583.7C.CrossRefPubMedPubMedCentral
5.
Marble A: Diabetes and cancer. New Engl J Med :. 1934, 211: 339-349. 10.1056/NEJM193408232110801.CrossRef
6.
Wideroff L, Gridley G, Mellemkjaer L, Chow WH, Linet M, Keehn S, Borch-Johnsen K, Olsen JH: Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst. 1997, 89: 1360-1365. 10.1093/jnci/89.18.1360.CrossRefPubMed
7.
Larsson SC, Permert J, Hakansson N, Naslund I, Bergkvist L, Wolk A: Overall obesity, abdominal adiposity, diabetes and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population-based cohorts. Br J Cancer. 2005, 93: 1310-1315. 10.1038/sj.bjc.6602868.CrossRefPubMedPubMedCentral
8.
Polesel J, Zucchetto A, Montella M, Dal Maso L, Crispo A, La Vecchia C, Serraino D, Franceschi S, Talamini R: The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma. Annals of Oncology. 2008, 20: 353-357. 10.1093/annonc/mdn565.CrossRefPubMed
9.
Donadon V: Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: Potential role of insulin. World Journal of Gastroenterology. 2008, 14: 5695-10.3748/wjg.14.5695.CrossRefPubMedPubMedCentral
10.
Larsson SC, Giovannucci E, Wolk A: Diabetes and colorectal cancer incidence in the cohort of Swedish men. Diabetes Care. 2005, 28: 1805-1807. 10.2337/diacare.28.7.1805.CrossRefPubMed
11.
Larsson SC, Orsini N, Wolk A: Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst. 2005, 97: 1679-1687. 10.1093/jnci/dji375.CrossRefPubMed
12.
Elwing JE, Gao F, Davidson NO, Early DS: Type 2 Diabetes Mellitus: The Impact on Colorectal Adenoma Risk in Women. The American Journal of Gastroenterology. 2006, 101: 1866-1871. 10.1111/j.1572-0241.2006.00651.x.CrossRefPubMed
13.
Larsson SC, Mantzoros CS, Wolk A: Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer. 2007, 121: 856-862. 10.1002/ijc.22717.CrossRefPubMed
14.
Larsson SC, Andersson SO, Johansson JE, Wolk A: Diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men. Eur J Cancer. 2008, 44: 2655-2660. 10.1016/j.ejca.2008.07.012.CrossRefPubMed
15.
Larsson SC, Wolk A: Diabetes mellitus and incidence of kidney cancer: a meta-analysis of cohort studies. Diabetologia. 2011, 54: 1013-1018. 10.1007/s00125-011-2051-6.CrossRefPubMed
16.
Kasper JS, Giovannucci E: A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2006, 15: 2056-2062. 10.1158/1055-9965.EPI-06-0410.CrossRefPubMed
17.
Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R: Diabetes and cancer. Endocrine Related Cancer. 2009, 16: 1103-1123. 10.1677/ERC-09-0087.CrossRefPubMed
18.
Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ: Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. American journal of epidemiology. 2004, 159: 1160-1167. 10.1093/aje/kwh161.CrossRefPubMed
19.
Oba S, Nagata C, Nakamura K, Takatsuka N, Shimizu H: Self-reported diabetes mellitus and risk of mortality from all causes, cardiovascular disease, and cancer in Takayama: a population-based prospective cohort study in Japan. Journal of epidemiology / Japan Epidemiological Association. 2008, 18: 197-203. 10.2188/jea.JE2008004.CrossRefPubMedPubMedCentral
20.
Woodward M, Zhang X, Barzi F, Pan W, Ueshima H, Rodgers A, MacMahon S: The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. Diabetes Care. 2003, 26: 360-366.CrossRefPubMed
21.
Ren X, Zhang X, Gu W, Chen K, Le Y, Lai M, Zhu Y: Type 2 diabetes mellitus associated with increased risk for colorectal cancer: evidence from an international ecological study and population-based risk analysis in China. Public Health. 2009, 123: 540-544. 10.1016/j.puhe.2009.06.019.CrossRefPubMed
22.
WHO: Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO Consultation. Part 1. Diagnosis and classification of diabetes mellitus. 1999, World Health Organization, Geneva
23.
Ogunleye AA, Ogston SA, Morris AD, Evans JM: A cohort study of the risk of cancer associated with type 2 diabetes. British journal of cancer. 2009, 101: 1199-1201. 10.1038/sj.bjc.6605240.CrossRefPubMedPubMedCentral
24.
Barone BB, Yeh H-C, Snyder CF, Peairs KS, Stein KB, Derr RL, Wolff AC, Brancati FL: Long-term All-Cause Mortality in Cancer Patients With Preexisting Diabetes Mellitus. JAMA: The Journal of the American Medical Association. 2008, 300: 2754-2764. 10.1001/jama.2008.824.CrossRefPubMed
25.
Kuriki K, Hirose K, Tajima K: Diabetes and cancer risk for all and specific sites among Japanese men and women. Eur J Cancer Prev. 2007, 16: 83-89. 10.1097/01.cej.0000228404.37858.40.CrossRefPubMed
26.
Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, Barzi F, Woodward M: Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. British journal of cancer. 2005, 92: 2076-2083. 10.1038/sj.bjc.6602619.CrossRefPubMedPubMedCentral
27.
Oba S, Nagata C, Nakamura K, Takatsuka N, Shimizu H: Self-reported Diabetes Mellitus and Risk of Mortality from All Causes, Cardiovascular Disease, and Cancer in Takayama: A Population-based Prospective Cohort Study in Japan. Journal of Epidemiology. 2008, 18: 197-203. 10.2188/jea.JE2008004.CrossRefPubMedPubMedCentral
28.
Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D: Diabetes and Cancer: A Consensus Report. CA: A Cancer Journal for Clinicians. 2010, 60: 207-221. 10.3322/caac.20078.
29.
Seow A, Yuan JM, Koh WP, Lee HP, Yu MC: Diabetes Mellitus and Risk of Colorectal Cancer in the Singapore Chinese Health Study. JNCI Journal of the National Cancer Institute. 2006, 98: 135-138. 10.1093/jnci/djj015.CrossRefPubMed
30.
Limburg PJ, Vierkant RA, Fredericksen ZS, Leibson CL, Rizza RA, Gupta AK, Ahlquist DA, Melton LJ, Sellers TA, Cerhan JR: Clinically Confirmed Type 2 Diabetes Mellitus and Colorectal Cancer Risk: A Population-Based, Retrospective Cohort Study. The American Journal of Gastroenterology. 2006, 101: 1872-1879. 10.1111/j.1572-0241.2006.00725.x.CrossRefPubMed
31.
Larsson SC, Orsini N, Brismar K, Wolk A: Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia. 2006, 49: 2819-2823. 10.1007/s00125-006-0468-0.CrossRefPubMed
32.
Smith MR, Bae K, Efstathiou JA, Hanks GE, Pilepich MV, Sandler HM, Shipley WU: Diabetes and Mortality in Men With Locally Advanced Prostate Cancer: RTOG 92–02. Journal of Clinical Oncology. 2008, 26: 4333-4339. 10.1200/JCO.2008.16.5845.CrossRefPubMedPubMedCentral
33.
Pierce BL, Plymate S, Ostrander EA, Stanford JL: Diabetes mellitus and prostate cancer risk. Prostate. 2008, 68: 1126-1132. 10.1002/pros.20777.CrossRefPubMed
34.
Pierce BL, Ahsan H: Genetic susceptibility to type 2 diabetes is associated with reduced prostate cancer risk. Hum Hered. 2010, 69: 193-201. 10.1159/000289594.CrossRefPubMedPubMedCentral
35.
Leitzmann MF, Ahn J, Albanes D, Hsing AW, Schatzkin A, Chang S-C, Huang W-Y, Weiss JM, Danforth KN, Grubb RL, Andriole GL: Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Causes & Control. 2008, 19: 1267-1276. 10.1007/s10552-008-9198-6.CrossRef
36.
Tran TT, Naigamwalla D, Oprescu AI, Lam L, Bruce WR, Giacca A: Hyperinsulinemia, But Not Other Factors Associated with Insulin Resistance, Acutely Enhances Colorectal Epithelial Proliferationin Vivo. Endocrinology. 2006, 147: 1830-1837.CrossRefPubMed
37.
Schoen RE, Weissfeld JL, Kuller LH, Thaete FL, Evans RW, Hayes RB, Rosen CJ: Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps. Gastroenterology. 2005, 129: 464-475.CrossRefPubMed
38.
Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, Dechaud H, Rinaldi S, Zeleniuch-Jacquotte A, Shore RE, Riboli E: Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. Journal of the National Cancer Institute. 2000, 92: 1592-1600. 10.1093/jnci/92.19.1592.CrossRefPubMed
39.
Sandhu MS, Dunger DB, Giovannucci EL: Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. Journal of the National Cancer Institute. 2002, 94: 972-980. 10.1093/jnci/94.13.972.CrossRefPubMed
40.
Wu X, Zhao H, Do KA, Johnson MM, Dong Q, Hong WK, Spitz MR: Serum levels of insulin growth factor (IGF-I) and IGF-binding protein predict risk of second primary tumors in patients with head and neck cancer. Clin Cancer Res. 2004, 10: 3988-3995. 10.1158/1078-0432.CCR-03-0762.CrossRefPubMed
41.
Yu H, Spitz MR, Mistry J, Gu J, Hong WK, Wu X: Plasma levels of insulin-like growth factor-I and lung cancer risk: a case–control analysis. Journal of the National Cancer Institute. 1999, 91: 151-156. 10.1093/jnci/91.2.151.CrossRefPubMed
42.
Jin T: Why diabetes patients are more prone to the development of colon cancer?. Medical hypotheses. 2008, 71: 241-244. 10.1016/j.mehy.2008.03.025.CrossRefPubMed
43.
Zheng W, McLerran DF, Rolland B, Zhang X, Inoue M, Matsuo K, He J, Gupta PC, Ramadas K, Tsugane S, et al: Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med. 2011, 364: 719-729. 10.1056/NEJMoa1010679.CrossRefPubMedPubMedCentral
44.
Li D, Yeung SC, Hassan MM, Konopleva M, Abbruzzese JL: Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology. 2009, 137: 482-488. 10.1053/j.gastro.2009.04.013.CrossRefPubMedPubMedCentral
45.
Bodmer M, Meier C, Krahenbuhl S, Jick SS, Meier CR: Long-term metformin use is associated with decreased risk of breast cancer. Diabetes Care. 2010, 33: 1304-1308. 10.2337/dc09-1791.CrossRefPubMedPubMedCentral
Metadata
Title
Increased risk of cancer in patients with type 2 diabetes mellitus: A retrospective cohort study in China
Authors
Pian-Hong Zhang
Zhong-Wen Chen
Duo Lv
Yu-Yang Xu
Wei-Ling Gu
Xu-Hui Zhang
Yuan-Luo Le
Hong-hong Zhu
Yi-Min Zhu
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2012
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-12-567

Other articles of this Issue 1/2012

BMC Public Health 1/2012 Go to the issue

Research article

Reduced cervical cancer incidence and mortality in Canada: national data from 1932 to 2006

Research article

Do positive or negative experiences of social support relate to current and future health? Results from the Doetinchem Cohort Study

Study protocol

An oral health literacy intervention for Indigenous adults in a rural setting in Australia

Research article

Survey of nasal carriage of Staphylococcus aureus and intestinal parasites among food handlers working at Gondar University, Northwest Ethiopia

Research article

Activities and sources of income after a period of long-term sick leave - a population-based prospective cohort study

Research article

Impact of drug price adjustments on utilization of and expenditures on angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in Taiwan